JPRN-UMIN000030718招募中未知
Combination of molecularly-targeted therapy with stereotactic body radiotherapy in hepatocellular carcinoma with major vascular invasion - Combination of molecularly-targeted therapy with SBRT in HCC with MVI
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The subject must be excluded if the subject; 1) Has the hepatic encephalopathy 2) Has the uncontrollable hypertension, heart failure, ischemic heart disease or arrhythmia. 3) Has had the acute myocardial infarction in the last 6 months. 4) Has the synchronous malignancies of other organs, or has had the metachronous ones in the last 2 years. 5) Has the serious psychiatric disorder or a serious decline in cognitive function. 6) Is pregnant or breastfeeding, or a female expecting to conceive a child. 7) Is judged to be inappropriate for the entry of this trial in the opinion of the treating investigator.
研究者
相似试验
已完成
不适用
Combination therapy with a molecular target drug and iron chelator for the treatment of intractable hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000013461Department of Gastroenterology, Okayama University Hospital10
招募中
不适用
The efficacy of molecular targeted therapy for unresectable hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000035136Kyoto University150
进行中（未招募）
不适用
Combination of antiangiogenic therapy using the mTOR-inhibitor RAD001 and low dose chemotherapy for locally advanced and/or metastatic pancreatic cancer – a dose finding studyadvanced and/or metastatic pancreatic cancerMedDRA version: 9.1Level: LLTClassification code 10033605Term: Pancreatic cancer metastaticEUCTR2006-003403-39-DEovartis Pharma GmbH
进行中（未招募）
不适用
Stereotactic body radiotherapy for the treatment of OPDung cancerCancerLung cancerISRCTN53398136Institute of Cancer Research110
已完成
4 期
Combination drug therapy for fibromyalgia paiMusculoskeletal DiseasesOther soft tissue disorders, not elsewhere classifiedFibromyalgiaISRCTN20173707Queen's University (Canada)69